iifl-logo-icon 1

Sanofi India Ltd Share Price

6,915.1
(0.26%)
Oct 11, 2024|03:32:33 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open6,900
  • Day's High6,950
  • 52 Wk High10,524.95
  • Prev. Close6,897
  • Day's Low6,836.15
  • 52 Wk Low 5,892.8
  • Turnover (lac)1,464.06
  • P/E32.31
  • Face Value10
  • Book Value545.17
  • EPS213.44
  • Mkt. Cap (Cr.)15,925.48
  • Div. Yield2.42
View All Historical Data
No Records Found

Sanofi India Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

6,900

Prev. Close

6,897

Turnover(Lac.)

1,464.06

Day's High

6,950

Day's Low

6,836.15

52 Week's High

10,524.95

52 Week's Low

5,892.8

Book Value

545.17

Face Value

10

Mkt Cap (₹ Cr.)

15,925.48

P/E

32.31

EPS

213.44

Divi. Yield

2.42

Sanofi India Ltd Corporate Action

23 Feb 2024

12:00 AM

Dividend

Dividend Amount: 117

Record Date: 03 May, 2024

arrow

8 Jul 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

23 Feb 2024

12:00 AM

AGM

Announcement Date: 23 Feb, 2024

arrow

22 Mar 2024

12:00 AM

BookCloser

arrow

13 Nov 2023

12:00 AM

EGM

arrow

Sanofi India Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Sanofi India Ltd SHAREHOLDING SNAPSHOT

12 Oct, 2024|06:28 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 60.39%

Foreign: 60.39%

Indian: 0.00%

Non-Promoter- 28.60%

Institutions: 28.60%

Non-Institutions: 10.99%

Custodian: 0.00%

Share Price

Sanofi India Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Dec-2023Dec-2022Dec-2021Dec-2020

Equity Capital

23

23

23

23

Preference Capital

0

0

0

0

Reserves

992.5

1,252.8

2,202.6

2,096

Net Worth

1,015.5

1,275.8

2,225.6

2,119

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Dec-2021Dec-2019Dec-2018Dec-2017

Revenue

2,956.6

3,070.6

2,770.8

2,463.6

yoy growth (%)

-3.71

10.81

12.46

4.08

Raw materials

-1,306.8

-1,347.4

-1,145.9

-1,004.1

As % of sales

44.19

43.88

41.35

40.75

Employee costs

-433.9

-449.7

-406.8

-368.5

View Profit & Loss
Y/e 31 Mar( In .Cr)Dec-2021Dec-2019Dec-2018Dec-2017

Profit before tax

768.4

659.2

609.8

514.6

Depreciation

-66.7

-99.9

-102.7

-102.2

Tax paid

-313.2

-185.7

-229.2

-188.6

Working capital

-30.59

457.2

126.6

-231.1

Other operating items

View Cash Flow
Y/e 31 MarDec-2021Dec-2019Dec-2018Dec-2017

Growth matrix (%)

Revenue growth

-3.71

10.81

12.46

4.08

Op profit growth

14.6

6.7

16.06

0.39

EBIT growth

16.78

8.02

18.38

6.83

Net profit growth

128

8.82

16.74

7.16

View Ratios
Particulars (Rupees in Crores.)Dec-2023Dec-2004Dec-2003

Gross Sales

1,996.1

794.09

707.2

Excise Duty

0

55.7

49.9

Net Sales

1,996.1

738.4

657.29

Other Operating Income

0

0

0

Other Income

317.3

26.6

21.29

Sanofi India Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,901.95

162.714,52,850.48237.820.724,409.7498.75

Divis Laboratories Ltd

DIVISLAB

6,142.25

94.941,57,701.614300.52,063507.93

Cipla Ltd

CIPLA

1,595.75

32.911,30,708.751,055.940.83,752.25346.39

Torrent Pharmaceuticals Ltd

TORNTPHARM

3,497.05

77.551,16,560.454690.812,394201.77

Dr Reddys Laboratories Ltd

DRREDDY

6,599.2

26.661,09,845.921,417.20.615,823.91,458.55

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Sanofi India Ltd

Management

Register Office

Registrar Office

Chairman & Independent Directo

Aditya Narayan

Independent Director

Usha Thorat

Whole Time Director & CFO

Vaibhav KARANDIKAR

Independent Director

Rahul Bhatnagar

Director

Marc-Antoine Lucchini

Director

Annapurna Das

Managing Director

Rodolfo Hrosz

Company Secretary

Radhika Shah

WTD & Additional Director

Renee Amonkar

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Sanofi India Limited, (Previously known as Aventis Pharma Limited) was incorporated in May, 1956. The Company changed its name from Aventis Pharma Limited to Sanofi India Limited on May 11, 2012. The Company is amongst the leading multinational companies (MNCs) in the Indian Pharmaceutical Market. The Company is primarily engaged in the business of manufacturing and trading of drugs s and pharmaceuticals. It has its own manufacturing facility at Goa. It sells products through independent distributors primarily in India.Sanofi Indias products viz. Lantus, Combiflam, Amaryl and Allegra feature in the top 100 pharmaceutical brands in India. The Company has its own manufacturing facility at Goa and Ankleshwar, Gujarat. It sells products through independent distributors primarily in India. Sanofi, one of the worlds leading pharmaceutical companies, and its 100% subsidiary, Hoechst GmbH, are the major shareholders of Sanofi India Limited and together hold 60.37% of its paid-up share capital. During the year 1997-98, the Joint Venture Company, Chiron Behring Vaccines Pvt Ltd started to manufacture anti-rabbies vaccine Rabipur. Roussel India Ltd was amalgamated with the Company with effect from April 1, 1997 and Hoechst Nepal (Pvt) Ltd, a subsidiary Company in Nepal was wound up during the year. During the year 1999-2000, Aventis launched anti-diabetic Amaryl broad spectrum anti-infective Tavanic and line extension of anti-hypertensive Cardace H. In the year 2001, Rhone-Poulenc Rorer
Read More

Company FAQs

What is the Sanofi India Ltd share price today?

The Sanofi India Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹6915.1 today.

What is the Market Cap of Sanofi India Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Sanofi India Ltd is ₹15925.48 Cr. as of 11 Oct ‘24

What is the PE and PB ratio of Sanofi India Ltd?

The PE and PB ratios of Sanofi India Ltd is 32.31 and 23.20 as of 11 Oct ‘24

What is the 52 Week High and Low of Sanofi India Ltd?

The 52-week high/low is the highest and lowest price at which a Sanofi India Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Sanofi India Ltd is ₹5892.8 and ₹10524.95 as of 11 Oct ‘24

What is the CAGR of Sanofi India Ltd?

Sanofi India Ltd's CAGR for 5 Years at 3.88%, 3 Years at -4.87%, 1 Year at -6.79%, 6 Month at -18.39%, 3 Month at 7.56% and 1 Month at -6.73%.

What is the shareholding pattern of Sanofi India Ltd?

The shareholding pattern of Sanofi India Ltd is as follows:
Promoters - 60.40 %
Institutions - 28.61 %
Public - 11.00 %

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS

  • Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020
  • Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.
  • Pay 20% upfront margin of the transaction value to trade in cash market segment.
  • Investors may please refer to the Exchange’s Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.
  • Check your Securities / MF / Bonds in the consolidated account statement issued by NSDL/CDSL every month.
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day.” – Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets – once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp